TORONTO, Aug. 21, 2020 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) today announced the appointment of Tricia Symmes as the Company’s Chief Commercial Officer, effective August 27, 2020.
Symmes brings over 20 years of experience as a senior executive in the pharmaceutical, consumer packaged goods, and cannabis industries. Reporting to Aleafia Health CEO Geoffrey Benic, she will lead the development and execution of the Company’s product launches, sales, marketing and corporate development initiatives in the adult-use, medical and international cannabis markets.
“Tricia’s leadership experience comes up at an exciting juncture for Aleafia Health as we strengthen and expand our adult-use and medical portfolios with new, differentiated health and wellness products,” said Benic. “Tricia’s proven track record and leadership in bringing best-in-class pharmaceutical, over-the-counter and innovative cannabis products to market will bring value to our patients, customers and shareholders as we enter a new and exciting phase in Aleafia Health’s development.”
“With a dynamic, industry-leading production ecosystem in place, this is an incredibly exciting time to join Aleafia Health. As we execute our Cannabis 2.0 strategy, the Company is poised to succeed with high-quality, innovative products at scale,” said Symmes. “Our team looks forward to expanding Aleafia Health’s product portfolio and establishing meaningful market share and brand recognition on both a national and global level as we open new market channels.”
Most recently, Ms. Symmes served as General Manager at CX Industries, a wholly owned subsidiary of WeedMD Inc. Ms. Symmes has extensive executive C-suite experience in the pharmaceutical, biotech and cannabis industries in both North American and international markets. Serving as chief operating officer and general manager of multinational public companies, including Alcon Canada and Novartis Pharmaceuticals, she has extensive CPG experience and is well-versed in consumer trends having led the development and execution of commercialization strategies, operations, business development, sales, and marketing. She holds an MBA from Charles Sturt University (Australia), and an Honours BSc in Kinesiology (Western University).
Following a transition period, Chief Marketing & Technology Officer Trevor Newell departs the Company effective August 28, 2020.
For Investor and Media Relations, please contact:
Nicholas Bergamini, VP Investor Relations
LEARN MORE: www.AleafiaHealth.com
About Aleafia Health:
Aleafia Health is a leading, vertically integrated cannabis health and wellness company with four primary business units: Cannabis Cultivation & Products, Health & Wellness Clinics, Cannabis Education, and Consumer Experience with ecommerce, retail distribution and provincial supply agreements.
Aleafia Health owns three major cannabis product & cultivation facilities, two of which are licensed and operational including the first large-scale, operational outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules and sprays. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and has international operations in three continents.
Innovation is at the heart of Aleafia Health competitive advantage. The Company maintains a medical cannabis dataset with over 10 million data points to inform proprietary illness-specific product development and its highly differentiated education platform FoliEdge Academy. The Company is committed to creating sustainable shareholder value and has been named the 2019 top performing company of the year by the TSX Venture Exchange prior to graduation to the TSX.
Forward Looking Information
This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.